| ACR | American College of Rheumatology |
| ANOVA | Analysis of Variance |
| ASyS | Anti-Synthetase Syndrome |
| AV/VA | Alveolar Volume |
| BL | B-Line |
| CK | Creatine Kinase |
| CTDs | Connective Tissue Diseases |
| DAD | Diffuse Alveolar Damage |
| DLCO | Diffusing Capacity of the Lungs for Carbon Monoxide |
| DM | Dermatomyositis |
| EC | Examiner/Operator Initials |
| EULAR | European Alliance of Associations for Rheumatology |
| FEV1 | Forced Expiratory Volume in the First Second |
| HAQ | Health Assessment Questionnaire |
| HRCT | High-Resolution Computed Tomography |
| IBM | Inclusion Body Myositis |
| IIM/IIMs | Idiopathic Inflammatory Myopathies |
| ILD | Interstitial Lung Disease |
| IMACS | International Myositis Assessment and Clinical Studies |
| LCQ | Leicester Cough Questionnaire |
| LDH | Lactate Dehydrogenase |
| LUS/Lung US | Lung Ultrasound |
| MAA | Myositis-Associated Autoantibody |
| MDA5 | Melanoma Differentiation-Associated Protein 5 |
| MMT8 | Manual Muscle Test (8 Muscles) |
| MRC | Medical Research Council |
| MSA | Myositis-Specific Autoantibody |
| MYOACT | Myositis Disease Activity Assessment Tool |
| NPV | Negative Predictive Value |
| NSIP | Non-Specific Interstitial Pneumonia |
| NXP-2 | Nuclear Matrix Protein 2 |
| OMERACT | Outcome Measures in Rheumatology |
| OP | Organizing Pneumonia |
| PFTs | Pulmonary Function Tests |
| PIs | Pleural Irregularities |
| PM | Polymyositis |
| PPV | Positive Predictive Value |
| PRO | Patient Reported Outcome |
| RA | Rheumatoid Arthritis |
| ROC | Receiver Operating Characteristic |
| SB | Second Operator Initials(iniziali) |
| SD | Standard Deviation |
| SGRQ | Saint George Respiratory Questionnaire |
| SLE | Systemic Lupus Erythematosus |
| SSc | Systemic Sclerosis |
| SRP | Signal Recognition Particle |
| TIF1γ | Transcription Intermediary Factor 1-gamma |
| TLC | Total Lung Capacity |
| UIP | Usual Interstitial Pneumonia |
| US | Ultrasound |
| VAS | Visual Analog Scale |
| VC | Vital Capacity |
| WS | Warrick Score |